BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22885367)

  • 1. A novel approach for nucleic acid delivery into cancer cells.
    Vainauska D; Kozireva S; Karpovs A; Čistjakovs M; Bariševs M
    Medicina (Kaunas); 2012; 48(6):324-9. PubMed ID: 22885367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal magnetofection.
    Mykhaylyk O; Sánchez-Antequera Y; Vlaskou D; Hammerschmid E; Anton M; Zelphati O; Plank C
    Methods Mol Biol; 2010; 605():487-525. PubMed ID: 20072903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic liposome mediated shRNA specifically suppresses the growth of non-small cell lung cancer in vitro and in vivo].
    Wang CM; Kong MJ; Dong AQ
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(5):341-4. PubMed ID: 22490840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo.
    Wang C; Ding C; Kong M; Dong A; Qian J; Jiang D; Shen Z
    Biochem Biophys Res Commun; 2011 Jul; 410(3):537-42. PubMed ID: 21683689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and gentle siRNA delivery by magnetofection.
    Ensenauer R; Hartl D; Vockley J; Roscher AA; Fuchs U
    Biotech Histochem; 2011 Aug; 86(4):226-31. PubMed ID: 20297946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene delivery to respiratory epithelial cells by magnetofection.
    Gersting SW; Schillinger U; Lausier J; Nicklaus P; Rudolph C; Plank C; Reinhardt D; Rosenecker J
    J Gene Med; 2004 Aug; 6(8):913-22. PubMed ID: 15293350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and characterization of liposomal magnetofection system in pig kidney cells].
    Chen W; Cui H; Zhao X; Cui J; Wang Y; Sun C
    Sheng Wu Gong Cheng Xue Bao; 2014 Jun; 30(6):972-81. PubMed ID: 25212014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
    Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
    Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro.
    Mykhaylyk O; Antequera YS; Vlaskou D; Plank C
    Nat Protoc; 2007; 2(10):2391-411. PubMed ID: 17947981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Varying Magnetic Fields on Targeted Gene Delivery of Nucleic Acid-Based Molecules.
    Oral O; Cıkım T; Zuvin M; Unal O; Yagci-Acar H; Gozuacik D; Koşar A
    Ann Biomed Eng; 2015 Nov; 43(11):2816-26. PubMed ID: 25963582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies.
    Jenkins SI; Pickard MR; Granger N; Chari DM
    ACS Nano; 2011 Aug; 5(8):6527-38. PubMed ID: 21721568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Insights Into the Nano Liposomal Magnetic Gene Vector Used for Cell Co-Transfection.
    Chen W; Cui H; Zhao X; Cui J; Wang Y; Sun C; Cui B; Lei F
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5530-6. PubMed ID: 26369113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and safe gene delivery to human corneal endothelium using magnetic nanoparticles.
    Czugala M; Mykhaylyk O; Böhler P; Onderka J; Stork B; Wesselborg S; Kruse FE; Plank C; Singer BB; Fuchsluger TA
    Nanomedicine (Lond); 2016 Jul; 11(14):1787-800. PubMed ID: 27388974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in magnetofection and its potential to deliver siRNAs in vitro.
    Mykhaylyk O; Zelphati O; Hammerschmid E; Anton M; Rosenecker J; Plank C
    Methods Mol Biol; 2009; 487():111-46. PubMed ID: 19301645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering.
    Yang SY; Sun JS; Liu CH; Tsuang YH; Chen LT; Hong CY; Yang HC; Horng HE
    Artif Organs; 2008 Mar; 32(3):195-204. PubMed ID: 18201284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery by magnetofection.
    Mykhaylyk O; Zelphati O; Rosenecker J; Plank C
    Curr Opin Mol Ther; 2008 Oct; 10(5):493-505. PubMed ID: 18830925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetofection is superior to other chemical transfection methods in a microglial cell line.
    Smolders S; Kessels S; Smolders SM; Poulhes F; Zelphati O; Sapet C; Brône B
    J Neurosci Methods; 2018 Jan; 293():169-173. PubMed ID: 28970164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene delivery into human cancer cells by cationic lipid-mediated magnetofection.
    Govindarajan S; Kitaura K; Takafuji M; Ihara H; Varadarajan KS; Patel AB; Gopal V
    Int J Pharm; 2013 Mar; 446(1-2):87-99. PubMed ID: 23415875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomagnetic activation as a way to control the efficacy of nucleic acid delivery.
    Grześkowiak BF; Sánchez-Antequera Y; Hammerschmid E; Döblinger M; Eberbeck D; Woźniak A; Słomski R; Plank C; Mykhaylyk O
    Pharm Res; 2015 Jan; 32(1):103-21. PubMed ID: 25033763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.